Literature DB >> 6490642

Coagulation Factor V contains copper ion.

K G Mann, C M Lawler, G A Vehar, W R Church.   

Abstract

Preparations of bovine and human coagulation Factor V were analyzed for copper using both atomic absorption and atomic emission spectroscopy. All preparations of the bovine and human protein were found to contain copper ion at a ratio of 1 copper ion bound per mol (Mr = 330,000) of Factor V. As a result of copper binding and sequence homology between ceruloplasmin and Factor V, bovine Factor V and thrombin-activated Factor V (Va) were assessed with respect to their visible and near ultraviolet absorption spectra and to their ability to oxidize N,N-dimethyl-p-phenylenediamine (a substrate for ceruloplasmin). Factor V and Factor Va exhibited absorption spectra with no maxima at either 310 or 610 nm, indicating that the copper is not bound in a site analogous to Type I or Type III copper sites in ceruloplasmin. Further, Factor V and Factor Va are not capable of serving as catalysts for the oxidation of N,N-dimethyl-p-phenylenediamine under solution conditions that are optimum for ceruloplasmin oxidase activity. These data suggest that the copper ion bound to Factor V may be functionally and structurally distinct from the Type I and Type III copper ion bound to ceruloplasmin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490642

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by size-exclusion chromatography-inductively coupled plasma atomic emission spectroscopy.

Authors:  Shawn A Manley; Simon Byrns; Andrew W Lyon; Peter Brown; Jürgen Gailer
Journal:  J Biol Inorg Chem       Date:  2008-09-10       Impact factor: 3.358

Review 3.  Combined factors V and VIII deficiency climbs onto the map.

Authors:  J E Sadler
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Complete cDNA sequence of human preceruloplasmin.

Authors:  M L Koschinsky; W D Funk; B A van Oost; R T MacGillivray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 6.  The role of insufficient copper in lipid synthesis and fatty-liver disease.

Authors:  Austin Morrell; Savannah Tallino; Lei Yu; Jason L Burkhead
Journal:  IUBMB Life       Date:  2017-03-08       Impact factor: 3.885

7.  Systematic evaluation of Copper(II)-loaded immobilized metal affinity chromatography for selective enrichment of copper-binding species in human serum and plasma.

Authors:  Samuel E Janisse; Vibha A Sharma; Amanda Caceres; Valentina Medici; Marie C Heffern
Journal:  Metallomics       Date:  2022-09-01       Impact factor: 4.636

8.  Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association.

Authors:  Abed R Zeibdawi; Jean E Grundy; Bogna Lasia; Edward L G Pryzdial
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

9.  The tertiary structure and domain organization of coagulation factor VIII.

Authors:  Betty W Shen; Paul Clint Spiegel; Chong-Hwan Chang; Jae-Wook Huh; Jung-Sik Lee; Jeanman Kim; Young-Ho Kim; Barry L Stoddard
Journal:  Blood       Date:  2007-10-26       Impact factor: 22.113

10.  Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.

Authors:  B O Villoutreix; B Dahlbäck
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.